Flow Pharma
East Palo Alto, CA
Flow Pharma offers a T-Cell based vaccine delivery platform. The vaccine platform has been tested in an HIV vaccine application (Immunity Project program in partnership with Until There’s A Cure) yielding promising results in animals and in human blood. Flow Pharma is now using a similar approach to develop a vaccine for Ebola, Marburg, and triple negative breast cancer. The company received the first breast cancer collaboration agreement at the largest cancer hospital in Saudi Arabia on 5/11/23. Flow Pharma has 10 issued patents in the US, EU, Canada and Australia and 10 published scientific articles can be found here www.flowpharma.com We are based in Cleveland, Ohio and Riyadh, Saudi Arabia.
flowpharma.comCompany Details
Founded
- 1999
Employees
- Between 5 - 20 employees
Raised
- $25,554,710
Headquarters Location
- East Palo Alto, CA
Public
- No
Acquired
- No
CEO
Reid Rubsamen
Founders
- Reid Rubsamen
Company Collections
These are collections Flow Pharma is a part of. Click on the collection name to view similar companies.